为评估 TFPI 对慢性肾病（CKD）和糖尿病患者动脉粥样硬化血栓事件（ATE）的预测能力，研究发现 TFPI 在 CKD 患者中可预测 ATE，意义重大。 在心血管疾病（CVD）的防治领域，寻找精准预测心血管风险的生物标志物一直是研究热点。想象一下，我们若能提前知晓哪些 ...

Still, Novo is steadfast in its goal to eventually become a leader in the space, the company’s EVP of rare disease, Ludovic ...

Citing that there is unmet medical need in the country for the proposed indication, the Subject Expert Committee (SEC) ...

The once-weekly anti-TFPI antibody has been cleared by the European Commission for adults and adolescents aged 123 and over with severe haemophilia A or B, without inhibitors, becoming the first ...

The tissue factor pathway inhibitor (TFPI) antagonist, given as a subcutaneous injection, has been cleared to prevent or reduce bleeding episodes in patients aged 12 years and older with ...

Martin Holst Lange, Executive Vice President, Development, Novo Nordisk, highlighted during the press briefing that their ...

Hympavzi is the first and only anti-tissue factor pathway inhibitor (anti-TFPI) approved in the U.S. for hemophilia A or B and the first hemophilia medicine approved in the U.S. to be administered ...

The X Factor news, contestants results and spoilers. X Factor UK latest on the shows, acts and judges.

Sepsis is a life-threatening clinical syndrome characterized by multiorgan dysfunction caused by a dysregulated or over-reactive host response to infection. During sepsis, the coagulation cascade is ...